Eli Lilly and Novo Nordisk raise profit outlook as weight-loss drug demand soars
Drugmakers’ share prices diverge as investors take dim view of Novo’s over-reliance on obesity treatme. Source: World. Read original report via source l…
Drugmakers’ share prices diverge as investors take dim view of Novo’s over-reliance on obesity treatme. Source: World. Read original report via source l…
Top LineThe experimental medicine ziltivekimab didn't translate into a statist. Source: US Top News and Analysis. Read original report via source l…
What Happenedpatients who recently started the pill following its launch and have v. Source: US Top News and Analysis. Read original report via source l…